OUP user menu

Cardio NewsWire

Please click here to view the archive of previous Cardio NewsWire stories. Each item is removed from the archive after 90 days.

NEW: EHJ Podcast

Dual antiplatelet treatment no benefit after 1 year from stenting

BCS 'A Year in Cardiology – 2014'


The new European Heart Journal Podcast series is launched

The EHJ with Oxford University Press are delighted to announce that Monday 17th November sees the launch of the first episode in the new, free, European Heart Journal podcast series.  The flagship podcast has been published alongside Dr Felix Mahfoud, and Professor Thomas Lüscher’s editorial "Renal denervation: Symply trapped by complexity?", which accompanies the Fast Track article "Predictors of blood pressure response in the SYMPLICITY HTN-3 trial" from David E. Kandzari et al.

The EHJ Podcast series joins the established suite of digital offerings from the EHJ, building pathways for cardiologists to discover and access the high-quality articles published in the Journal. Each podcast will publish in conjunction with a key Hotline Paper providing an audio summary of the article which can be downloaded and listened to for free.

Not only will cardiologists be able to access the EHJ Podcast series via links from the online table of contents and the Hotline Papers themselves, but individual episodes can be downloaded and listened to via podcast managers such as iTunes. You can also subscribe to the series and receive the latest episodes straight to your device.

With the addition of the EHJ Podcast series you can now listen, watch, and read cutting edge research from the EHJ anytime, anywhere.

The podcasts are available at: eurheartj.oxfordjournals.org/podcast


ARCTIC-Interruption trial finds no benefit of DAPT beyond 1 year after stenting

Dual antiplatelet treatment (DAPT) beyond 1 year after drug-eluting stent (DES) implantation provides no benefit and may be harmful in patients with no events in the first year, according to the results of the ARCTIC-Interruption trial.

The trial was a planned extension of the ARCTIC-Monitoring trial, which randomised 2440 patients to a strategy of platelet function testing with antiplatelet treatment adjustment or a conventional strategy after DES implantation. After 1 year, patients with no contraindication to interruption of DAPT were re-randomised to either interruption (624 patients) or continuation (635 patients) of DAPT for a further 6-18 months (ARCTIC-Interruption trial). The primary endpoint was a composite of death, myocardial infarction, stent thrombosis, stroke, or urgent revascularisation, analysed by intention to treat.

After 17 months, there were no differences between the two groups in the primary endpoint, which occurred in 4% of patients in both groups. STEEPLE major bleeding events were more frequent in the continuation (1%) compared to the interruption group (<0.5%) but the difference was not significant. There were significantly more major or minor bleedings in the continuation (2%) versus the interruption group (1%) (p=0.04).

The trial demonstrates that 1 year after stenting just half of the patients could be randomised leading to selection of a low risk population. No conclusions can be made for high-risk patients as they were not randomised.

The authors recommend that guidelines be revisited in favour of shorter duration of DAPT after stenting.

The article can be found here.


British Cardiovascular Society ‘A Year in Cardiology – 2014’

‘A Year in Cardiology’ is a very popular one-day symposium, which returns to the Royal College of Physicians in London for its fourth year. Held annually at the end of the international conference calendar by the British Cardiovascular Society, it has rapidly become an essential opportunity for cardiologists to update themselves with the year’s most important developments in Cardiology.

The internationally renowned expert faculty will present a comprehensive review of the headline news for the year. The much anticipated keynote lecture this year will be given by Professor Philippe Gabriel Steg, Professor of Cardiology at the Université Paris and Imperial College London, a leading figure in coronary artery disease.

The morning session provides a succinct update on the important ESC and NICE Guideline updates, whilst the afternoon session reviewing key developments in all major cardiology subspecialties. At the end of each session delegates have the opportunity to pose questions to the speakers in the ‘Ask the Expert’ debate.

This year’s conference will be held on Friday 12 December 2014. The symposium is accredited by EBAC with delegates earning 6 CME or CPD for attendance.

For details on ‘A Year in Cardiology - 2014’ and other symposia run by the British Cardiovascular Society please see www.bcs.com/education/.


Back to top